EUVIMEDEUVIMED entdecken
Open Access

In Vivo Stimulation of Therapeutic Antigen‐Specific T Cells in an Artificial Lymph Node Matrix

Natalie K Livingston iD, John W Hickey, Hajin Sim, Sebastian F Salathe, Joseph Choy, Jiayuan Kong, Aliyah B Silver, Jessica L Stelzel, Mary O Omotoso, Shuyi Li, Worarat Chaisawangwong, Sayantika Roy und 10 weitere

Advanced Materials · 2024-06 · 36 (23)

DOI: 10.1002/adma.202310043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2024-03. Verfasst von Natalie K Livingston und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD, 21205, USA. Hauptthemen laut MEDLINE: Lymph Nodes, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, NCI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T cells are critical mediators of antigen‐specific immune responses and are common targets for immunotherapy. Biomaterial scaffolds have previously been used to stimulate antigen‐presenting cells to elicit antigen‐specific immune responses; however, structural and molecular features that directly stimulate and expand naïve, endogenous, tumor‐specific T cells in vivo have not been defined. Here, an artificial lymph node (aLN) matrix is created, which consists of an extracellular matrix hydrogel conjugated with peptide‐loaded‐MHC complex (Signal 1), the co‐stimulatory signal anti‐CD28 (Signal 2), and a tethered IL‐2 (Signal 3), that can bypass challenges faced by other approaches to activate T cells in situ such as vaccines. This dynamic immune‐stimulating platform enables direct, in vivo antigen‐specific CD8+ T cell stimulation, as well as recruitment and coordination of host immune cells, providing an immuno‐stimulatory microenvironment for antigen‐specific T cell activation and expansion. Co‐injecting the aLN with naïve, wild‐type CD8+ T cells results in robust activation and expansion of tumor‐targeted T cells that kill target cells and slow tumor growth in several distal tumor models. The aLN platform induces potent in vivo antigen‐specific CD8+ T cell stimulation without the need for ex vivo priming or expansion and enables in situ manipulation of antigen‐specific responses for immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymph NodesCD8-Positive T-LymphocytesAnimalsMiceLymphocyte ActivationHydrogelsImmunotherapyExtracellular MatrixCD28 AntigensHumansInterleukin-2PeptidesCell Line, TumorMice, Inbred C57BL

Stichwörter der Autor:innen

T cell stimulationadoptive T cell therapyartificial lymph nodecancerhydrogelimmunotherapyin vivo activation

Substanzen

HydrogelsCD28 AntigensInterleukin-2Peptides

Autor:innen und Institutionen

  • Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD, 21205, USA.
  • Institute for Cell Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD, 21205, USA.
  • Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD, 21205, USA.
  • Translational Tissue Engineering Center, Johns Hopkins University, Baltimore, MD, 21231, USA.
  • Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD, 21218, USA.
  • Department of Biology, Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, MD, 21218, USA.

ORCID-Profile: Natalie K Livingston, Jonathan P Schneck

Förderung

  • NIBIB NIH HHS
  • NCI NIH HHS
  • NIAID NIH HHS
  • NIH HHS
  • National Science Foundation
  • Natural Sciences and Engineering Research Council of Canada's
  • National Institutes of Health

Zitieren

APA

Livingston, N. K., Hickey, J. W., Sim, H., Salathe, S. F., Choy, J., Kong, J., Silver, A. B., Stelzel, J. L., Omotoso, M. O., Li, S., Chaisawangwong, W., Roy, S., Ariail, E. C., Lanis, M. R., Pradeep, P., Bieler, J. G., Witte, S. E., Leonard, E., Doloff, J. C., …, & Schneck, J. P. (2024). In Vivo Stimulation of Therapeutic Antigen‐Specific T Cells in an Artificial Lymph Node Matrix. Advanced Materials, 36(23). https://doi.org/10.1002/adma.202310043

Vancouver

Livingston NK, Hickey JW, Sim H, Salathe SF, Choy J, Kong J, et al. In Vivo Stimulation of Therapeutic Antigen‐Specific T Cells in an Artificial Lymph Node Matrix. Advanced Materials. 2024;36(23). doi:10.1002/adma.202310043

BibTeX
@article{Livingston2024,
  author = {Livingston, Natalie K and Hickey, John W and Sim, Hajin and Salathe, Sebastian F and Choy, Joseph and Kong, Jiayuan and Silver, Aliyah B and Stelzel, Jessica L and Omotoso, Mary O and Li, Shuyi and Chaisawangwong, Worarat and Roy, Sayantika and Ariail, Emily C and Lanis, Mara R and Pradeep, Pratibha and Bieler, Joan Glick and Witte, Savannah Est and Leonard, Elissa and Doloff, Joshua C and Spangler, Jamie B and Mao, Hai-Quan and Schneck, Jonathan P},
  title = {In Vivo Stimulation of Therapeutic Antigen‐Specific T Cells in an Artificial Lymph Node Matrix},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {23},
  doi = {10.1002/adma.202310043}
}
Kostenlos starten →